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Abstract 6 
Background: Experts suggests formulary alerts at medication order entry is the most effective 7 
form of clinical decision support to automating formulary management.   8 
Objective: Our objectives was to quantifying the frequency of inappropriate NFM alert 9 
overrides in the inpatient setting and provide insight on how to better design formulary alerts 10 
for automated formulary management.  11 
Methods: The NFM alert overrides of 206 highest costing and most utilized NFM from 2012 12 
were randomly selected for appropriateness evaluation. Using an empirically developed NFM 13 
alert appropriateness algorithm, appropriateness of NFM alert overrides were assess by two 14 
pharmacist via in-depth chart review. Appropriateness agreement of NFM alert overrides was 15 
assessed with a Cohen’s kappa. Exploratory analysis assessed which types of NFMs were most 16 
likely to be inappropriately overridden, which type of override reasons was disproportionately 17 
associated with inappropriate alert overrides, and what reasons explained why a NFM alert was 18 
overridden inappropriate. 19 
Results: Approximately 17.5% (n=36/206) of NFM alerts are inappropriately overridden. Non-20 
oral NFMs alerts are more likely to be inappropriately overridden compared to oral NFMs. 21 
Alerts overridden with ‘blank’ reasons were more likely to be inappropriate. The failure to first 22 
trial a formulary alternative is the most common reason for a NFM alert overridden 23 
inappropriately.  24 
Conclusion: Conservatively about one in five NFM alert overrides are overridden 25 
inappropriately. Mandating an override reason for each NFM alert override and adding a list of 26 
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formulary alternatives to each NFM alert may decrease the frequency of inappropriate NFM 27 
alert overrides.  28 
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Introduction 29 
A hospital formulary is a list of medications agreed upon by hospital healthcare providers 30 
for the care of admitted patients.1 Medications on this list are often the cost-effective option 31 
compared to their non-formulary alternatives, also termed non-formulary medications (NFMs). 32 
Typically, NFMs are not stocked and require special order entry and procurement procedures 33 
by the prescriber and pharmacy prior to use. These special order entry and procurement 34 
procedures increases labor cost ($15.94 to $23.34)2-4 and can substantially delay NFM initiation 35 
(10.6 hours).3 NFMs are also error prone, because they are unfamiliar to hospital staff may be 36 
misinterpret for the more familiar formulary medications.5-8  37 
However, the need for hospitals to provide NFMs is inevitable. There are times when 38 
admitted patients are stabilized on a pre-admission, chronic NFM and substitution with a 39 
formulary alternative can induce harm. Experts suggests formulary CDS, at medication order 40 
entry, in the form of a pop-up alert containing a list of formulary alternatives is the most 41 
effective design in balancing the need of NFMs while limiting the ill-effects of formulary non-42 
compliance.9 Empiric verification of this suggestion is limited. Analogous evidence can be drawn 43 
from the more commonly used computerized alerts (drug-allergy, drug-drug interactions, drug-44 
disease contraindication, etc.), where studies have shown these alerts improve prescribing 45 
behaviors, reduce prescribing errors, impact clinical outcomes, and decrease medication cost.10 46 
However, these benefits have often been challenged by the high frequency of alert overrides 47 
(49-96%).11 Therefore, we are unsure if the aforementioned alerts benefits can be generalized 48 
to formulary alerts. 49 
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To our knowledge there are no studies evaluating the appropriateness of NFM alert 50 
overrides. Our experience suggests this may be attributed to the resource-intensive task of 51 
creating appropriateness criteria for each NFM. In our previous study, we empirically developed 52 
a ‘general’ appropriateness algorithm that institutions could adapted to evaluate the 53 
appropriateness of their institution specific NFM alert overrides. We adapted this general 54 
algorithm to our institution’s NFM use policy and criteria and evaluated the appropriateness of 55 
a random sample of NFM alert overrides.  56 
Methods 57 
Setting 58 
Brigham and Women’s Hospital (BWH) is a 793-bed academic medical center located in 59 
Boston, MA and admits approximately 46,000 patients annually for a full range of inpatient 60 
services, with the exception of pediatrics. Medications available for patient care are governed 61 
by BWH’s formulary. Inpatient medications are ordered through an in-housed developed 62 
computerized provider order entry (CPOE) system inside Brigham Integrated Computer System 63 
(BICS). Full details of BICSand the CPOE system are described elsewhere.12 Formulary alerts 64 
embedded in the CPOE system are used to automate formulary management. Upon order entry 65 
of a NFM, prescribers are informed of its non-formulary status with three types of pop-up 66 
alerts: 1) a ‘soft stop’ requesting the input of a free-texted override reasons, explaining the 67 
rationale of formulary deviation, 2) an ‘intermediate stop’ requesting an override reason and 68 
the identifying the specialist physician who approved the NFM for use, and 3) a ‘hard stop’ 69 
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stating the NFM is not available for use and prompting the prescriber to order the preferred 70 
formulary alternative (Figure 1 and 2). 71 
  
Figure 1: Non-formulary medication alerts 
The dashed line represents the hard stop directing the prescriber to order a preferred NFM 
alternative. In this example Quetiapine XR cannot be ordered, but the hard stop directs the 
prescriber to order Quetiapine which is also NFM. The soft stop directs the provider to enter a 
reason why NFM is needed. 
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Figure 2: Non-formulary pop-up alerts 
 A) Soft stop, B) Intermediate stop, and C) Hard stop  
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Study Design and Sampling of NFM alert overrides 72 
The present study was an observational study of NFM alerts overridden from January 1st 73 
to December 31st, 2012. These overrides and their relevant data elements were extracted from 74 
BICS and loaded into a Microsoft Access Database (Microsoft Corp, Redmond, WA). Relevant 75 
data elements included patient’s medical record number, patient name, admission date, 76 
discharge date, NFM order entry date, NFM order entry time, medication unique identifier, 77 
generic medication name, route, dosage, dosing frequency, estimated number of doses 78 
required, , prescriber name, prescriber unique identifier, and the free-texted NFM alert 79 
override reason.   80 
We limited our sample of NFM alert overrides to only original overrides and excluded 81 
those that were the result of medication dose, direction, or frequency changes. The latter 82 
overrides’ rational for formulary deviation were often the same as the original and including 83 
them into our evaluation would duplicate alerts. Further, at BWH there are two sources of non-84 
formulary designation, one in BICS and the other in an online formulary dictionary. Our internal 85 
study found inconsistencies in these two sources. To ensure our evaluation included only true 86 
NFMs, we further limited our overrides sample to medications listed as non-formulary in both 87 
sources. 88 
Total medication cost, composed of procurement and medication cost from 2009 to 89 
2012, were computed for each NFM. The average procurement cost of providing a NFM over 90 
formulary alternatives was estimated to be $20.07 per order.2 This estimate was used to 91 
convert the number of NFM orders to a monetary value. Medication costs were estimated from 92 
a BWH’s medication wholesaler account during the first quarter of 2014. NFMs were ranked 93 
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from highest to lowest total cost and twenty alert overrides were randomly selected from the 94 
top 11 NFMs for alert override appropriateness evaluation. Figure 3 describes our NFM alert 95 
override sampling scheme.  96 
 
Figure 3: NFM alert override random selection  
𝟁Top 11 most approved and highest costing NFMs 
ɣIn 2012 there were only six alert overrides for liposomal doxorubicin  
 97 
NFM alert override appropriateness criteria  98 
2012 NFM alert Overrides 
(approvals) 
N = 71,145 
Original NFM alert 
Overrides 
N = 59,102 
NFM alert Overrides 
N = 206
ɣ
 
Random selection of 20 alert overrides 
Top 11 NFMs’ 
Alert Overrides  
N = 11,918
𝟁�
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Previously, we empirically developed a general NFM alert override appropriateness 99 
algorithm from free-texted NFM alert override reasons. Full details of the methodology and 100 
performance of the algorithm can be found elsewhere (citation AJHP Study). In brief, a NFM 101 
alert override reason categorization scheme was created from a random sample of 5,000 102 
overrides according to keywords, context, and value explaining the rationale for formulary 103 
deviation. A 30 question appropriateness algorithm was initially developed from these override 104 
reason categories and presented to an interdisciplinary team of healthcare providers to 105 
evaluate clinical creditability and for feedback. BWH inpatient pharmacist and pharmacy 106 
administrators were also consulted on the NFM ordering process and the algorithm was 107 
simplified to an eight question general appropriateness algorithm (Figure 4). Available BWH 108 
medication monographs, treatment guidelines and medication administration guidelines of the 109 
top 11 NFMs were ascertained from the BWH Pharmacy intranet website and incorporated into 110 
the general algorithm to create insitution specific NFM alert override algorithms. 111 
  112 
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Figure 4: General NFM alert override appropriateness algorithm 
Is the NF override reason 
blank or of marginal 
value in evaluating NFM 
appropriateness?
No
Is this NFM 
contraindicated in 
this patient?
Yes
Yes
Can this NFM 
significantly augment or 
induce any of the patient’s 
disease states found on 
the patients medical 
history, allergies, or drug 
interactions? 
Yes
Document NFM request as 
“Inappropriate”
Is there a 
formulary 
alternative for the 
NFM?
No
No
Has the NFM been 
previously used in the 
outpatient or pre-
admission setting? 
(home medication)
Document NFM request 
as “Inappropriate”
Document NFM request as  
“Appropriate”Yes
Is there clinical evidence or 
documented reason to support the 
use of the NFM over the formulary 
alternative? 
(indication, route conflict, NPO,
evidence patient failed formulary 
alternative, specialist 
recommendation, others)
Yes
No
Yes
Yes
Document NFM request as  
“Appropriate” 
No
Document NFM request as  
“Appropriate”
Have at least one 
formulary alternative / 
option  been tried?
No
Is there a 
documented reason 
why the formulary 
alternative was not 
tried?
No
Yes
No
Document NFM request as 
“Inappropriate”
 
  113 
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Chart review and appropriateness evaluation 114 
An appropriateness evaluation interface was created in a Microsoft Access Form, where 115 
all aforementioned relevant data elements were displayed. This was an attempt to mimic 116 
formulary management at the at the point of care. All inpatient notes in “portable document 117 
format” (PDF) corresponding to the hospitalization when the NFM alert was overridden was 118 
downloaded from BICS and a hyperlink to this document was created in the Microsoft Access 119 
Form to facilitate reviewer access. All medication orders, labs, and medication administration 120 
logs during hospitalization were available through BICS. Outpatient medication records were 121 
available through BWH’s ambulatory care electronic medical record, Longitudinal Medical 122 
Record (LMR).  123 
Two pharmacists (QLH and MGA) assess the appropriateness of each NFM alert override 124 
according to the institution specific NFM appropriateness algorithms via in-depth chart. 125 
Generally, pharmacists first reviewed the override reason explaining the formulary deviation 126 
and identified ‘preliminary’ formulary alternatives to the NFM. Second, the pharmacists 127 
ensured that the NFM was not contraindicated or potentially induced any significant harm to 128 
the patient according to the information found in the  inpatient chart (i.e. chief complaint of 129 
admission, medical history, allergies, or drug interactions). If the NFM posed any threat of 130 
harming the patient, the NFM alert override was considered inappropriate. The reviewers also 131 
reviewed medication orders and medication administration logs for evidence of trialing 132 
formulary alternatives prior to the NFM alert override. The NFM alert override was considered 133 
appropriate if a formulary alternative was first tried or documentation in the inpatient notes 134 
reasonably explained why a formulary alternative was not an option, otherwise the NFM alert 135 
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override was inappropriate. Disagreements between pharmacists were resolved by discussion 136 
with a third reviewer (DLS). 137 
In our previous study, approximately one-half of all NFM alerts overrides were justified 138 
with entered blanks  and marginal value reasons (i.e. patient needs medication, patient 139 
requires, attending prefers, etc.) (AJHP citation).  It is possible that these overrides are 140 
appropriate, but justification was poorly documented. For example, there could be occasions 141 
where specialist were consulted or formulary alternatives were thoroughly evaluated and 142 
found to induced drug interactions, but the prescriber passively entered a ‘blank’ or marginal 143 
value reason in the NFM alert override interface. Thus, ‘blank’ and marginal value reasons were 144 
deemed inappropriate unless an appropriate justification (specialist consult, pharmacological 145 
interaction, active disease that required the medication etc) for the NFM was discovered during 146 
chart review.  147 
Our previous study, we also found a significant number of NFM alert overrides were 148 
justified with syntax variants of the NFM being a pre-admission or home medication. In these 149 
cases the NFM alert override was considered appropriate only if the NFM was found active in 150 
the LMR’s electronic medication list during the dates of hospitalization. For NFMs justified by a 151 
‘disease or condition’ reason, the literature was searched to ensure minimal supporting 152 
evidence existed (at least a case-report) for the NFM’s proposed indication. Any level of clinical 153 
evidence found concluding effectiveness and citation of the ‘disease or condition’ in the 154 
inpatient notes prompted these overrides to be deemed as appropriate. Remaining potential 155 
reasons included specialist or pharmacist recommendation, therapeutic failure or intolerance 156 
to NFMs, pharmacological reasons, end of life care, and drug shortages. NFM alerts overridden 157 
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with these reasons were appropriate as long as there was documented evidence in the 158 
inpatient notes. For example, olanzapine was often justified with ‘per psych recommendation,’ 159 
this NFM alert override would be considered appropriate if a psychiatrist consult 160 
recommending the medication was existed in the inpatient notes prior the NFM being ordered.  161 
Outcomes and objectives 162 
Our primary objective was to quantify the frequency of NFM alerts overridden 163 
inappropriately, computed as the ratio of NFM alerts overridden not according to our 164 
appropriateness algorithms over the total number of overrides in our sample. Secondary 165 
objectives included identifiying (1) which types of NFMs (oral and non-oral) were most likely to 166 
be inappropriately overridden, (2) which category of NFM alert override reasons 167 
disproportionately represent inappropriate NFM alert overrides, and (3) reasons explaining why 168 
the NFM alert override was inappropriate. A post-hoc analysis was report the frequency of 169 
override reason given in NFM alert pop-up not congruent to the formulary deviation reason 170 
documented in the inpatient notes; we term these discrepancies as discordant override 171 
reasons. 172 
Statistical Analysis 173 
Counts and frequencies were used to summarize the number of inappropriate overrides 174 
according to our NFM alert override reason categorization scheme. Agreement in the 175 
inappropriateness of NFM alert overrides between the two pharmacists was evaluated with a 176 
Cohen’s kappa. Fischer’s exact test was used to compare the distribution of inappropriate NFM 177 
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alert overrides among oral and non-oral NFMs. A p-value of less than 0.05 was considered to be 178 
statistically significant. 179 
A Fischer’s exact test was also first used to determine if inappropriate NFM alert 180 
overrides were disproportionately distributed among the override reasons categories. If the 181 
exact test was found to be statistical significant (p-value < 0.05), the frequency of 182 
inappropriate overrides in each override reason category was compared to the frequency of 183 
the override reasons using a student t-test. A Bonferroni correction was applied to the student 184 
t-test to adjust for multiple testing. All statistical analyses were conducted using SAS software 185 
(version 9.4 SAS Institute, Cary, NC). This study was approved by the Partners Human Research 186 
Committee.  187 
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Results 188 
Table 1 
Top 11 Most Approved 
and Highest Costing NFMs   
Number of 
NFM Alert 
Overrides 
Inappropriate 
Alert 
Overrides 
Frequency of 
Inappropriate 
Alert Override 
Percentage of 
Total 
Inappropriate 
Alert Overrides 
Oral non-formulary medications (n=80, 38.8%) 
Aprepitant (PO) 20 0 0.0% 
13.9% 
Olanzapine (PO) 20 0 0.0% 
Olanzapine ODT (PO) 20 1 5.0% 
Quetiapine (PO) 20 4 20.0% 
Non-oral non-formulary medications (n= 126, 61.2%) 
Dornase Alfa (Neb) 20 4 20.0% 
86.1% 
Liposomal Doxorubicin (IV) 6 0 0.0% 
Metronidazole 1% (Cream) 20 6 30.0% 
Mometasone Furoate 
(Inhaler) 20 
4 20.0% 
Ranitidine (IV) 20 16 80.0% 
Rasburicase (IV) 20 0 0.0% 
Scopolamine (Patch) 20 1 5.0% 
Total 206 36 17.5% 100.0% 
 189 
In 2012, 71,145 NFM alerts were overridden, of which 59,102 were original alert 190 
overrides for 45,352 hospitalizations. Thus, about 1.3 original NFM alerts were overridden with 191 
each hospitalization. The top 11 most approved and highest costing NFMs can be found in 192 
Table 1. Four NFMs were oral medications, of which three were atypical antipsychotics. The 193 
remaining seven included three intravenous medications, two inhalants, and two topicals. The 194 
random selection scheme selected 206 NFM alerts overrides from these medications (there 195 
were only six liposomal doxorubicin orders in 2012), which were prescribed by 174 distinct 196 
health care providers: 150 physicians, 21 physician-assistants, and three pharmacists.  197 
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According to the appropriateness algorithms, the two pharmacists found 36 (17.5%) 198 
NFM alerts inappropriately overridden (Table 1). Agreement between reviewers was high, 199 
κ=0.97 (95% CI: 0.92 – 1.00). Inappropriate alert overrides were disproportionately nested in 200 
non-oral NFMs (p=0.007), where 86.1% (n=31) of inappropriate alert overrides were from non-201 
oral NFMs, while they constituted only 61.2% of the alert override sample (Table 1).  202 
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Table 2: Non-Formulary Medication Alert Override Appropriateness Evaluation 
Initiate Non-Formulary Override Reason 
Classification 
Total Number (Percentage of 
Total) 
Final Appropriateness Evaluation 
Appropriate 
Inappropriate 
(Percentage of 
Total) 
P-
Value
1
 
Blank 51 (24.8%) 31 20 (55.6%) 0.0001 
Disease or Condition Listed 64 (31.1%) 60 4 (11.1%) 0.0004 
Home or Pre-Admission Medication 38 (18.4%) 33 5 (13.9%) 0.4401 
Marginal Value for NF Decision:  30 (14.6%) 26 4 (11.1%) 0.5204 
Acknowledge NF status 2 (1%) 2 0 (0%)   
Content Free 1 (0.5%) 1 0 (0%)   
MD/Attending/Team Request, Prefers NF Medication 11 (5.3%) 8 3 (8.3%)   
MisCommunication: Medication use direction 3 (1.5%) 3 0 (0%)   
Others 2 (1%) 2 0 (0%)   
Patient Preference/Request 2 (1%) 2 0 (0%)   
Reason Listed "Appropriate, Effective, Indicated, 
Medical Necessity, No Alternative 
1 (0.5%) 1 0 (0%)   
Reason Listed "Need*/Requir* OR Patient 
Need*/Require* 
8 (3.9%) 7 1 (2.8%)   
Pharmacological Reason:  4 (1.9%) 3 1 (2.8%) 0.6908 
Contraindication 1 (0.5%) 1 0 (0%)   
Drug Route Conflict 1 (0.5%) 0 1 (2.8%)   
Others 2 (1%) 2 0 (0%)   
Specialist Recommendation 10 (4.9%) 9 1 (2.8%) 0.4442 
Therapeutic Failure / Intolerant to formulary 
alternatives:  
9 (4.4%) 8 1 (2.8%) 0.6092 
Medication Listed 6 (2.9%) 6 0 (0%)   
Unspecified or Medication Not Listed 3 (1.5%) 2 1 (2.8%)   
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Total 206 170 36   
1P-values  less than 0.007 (=0.05/7) were considered statistically significant, after application of a Bonferroni correction.   
  203 
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There were 117 unique override reasons in the 206 NFM alert override sample. These 204 
reasons were categorized into 17 of the 24 previously developed override reason categories 205 
(Table 2). The most common reason explaining formulary deviation was the provision of a 206 
‘disease or condition’ (31.1%, n=64). No (‘blank,’ n=51) or marginal value reasons (n=30) were 207 
provided in 39.4% of the alert override sample. ‘Home or Pre-Admission Medications’ reasons 208 
were used to justify for 18.4% (n=38) and clinical reasons of pharmacological, specialist 209 
recommendation, and failure or intolerance to formulary alternatives definition for only 11.2% 210 
(n=23) of the NFM alert override sample.  211 
Fischer’s exact test confirmed a disproportionate distribution of inappropriate overrides 212 
among the categories of override reasonsin our sample of alert overrides, p< 0.001. Specifically, 213 
subanalysis found 55.6% (n=20) of inappropriate overrides were nested in the ‘blank’ override 214 
reason category, while ‘blanks’ only accounted for 24.8% of all override reasons, p=0.0001. 215 
Contrary, 11.1% of inappropriate overrides were nested in the ‘disease or condition’ reason 216 
category, while these reasons accounted for 31.1% of the reasons in our sample, p=0.0004. 217 
Statistical analysis did not find a disproportionate number of inappropriate overrides in the 218 
remaining override reason categories (Table 2).   219 
Chart reviews identified 24 (66.7%) of the 36 inappropriate NFM alert overrides were 220 
the result of not trialing formulary alternatives prior to the NFM (Table 3). Eight (22.2%) of the 221 
inappropriate NFM alert overrides were justified as a pre-admission or home medication, but 222 
no evidence of active outpatient prescription was found in the patient’s LMR. Chart reviews 223 
also found no or limited information justifying the use of the NFMs in three (8.3%) 224 
inappropriate overrides. These overrides were overridden with a ‘blank’ or marginal value 225 
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reason (prescriber preference). Lastly, there was one case where the NFM was deemed 226 
clinically inappropriate to the patient involving the use of an atypical antipsychotic to address 227 
dementia in an elderly patient, which has been linked to adverse outcome in chronic and as-228 
needed used.13,14 Post-hoc analysis identified found ‘blank’ and marginal value reasons have the 229 
highest frequency of discordant override reasons, 94.1% and 93.3%, respectively (Table 4). 230 
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Table 3: Reasons explaining why the NFM alert override was considered inappropriate  
Non-Formulary Alert Override 
Reason Class 
Total 
Formulary 
alternative was 
not first trial 
prior to NFM 
alert override 
No citation or 
information 
could be found 
justifying 
formulary 
deviation during 
chart review 
Clinically 
Inappropriate 
No evidence 
of active 
home 
medication 
found in LMR 
No documentation 
of specialist 
recommendation 
during chart review 
Blank 20 17 1 0 2 0 
Disease or Condition Listed 4 4 0 0 0 0 
Home or Pre-Admission 
Medication 
5 0 0 0 5 0 
Marginal Value for NF Decision: 
MD/Attending/Team Request, 
Prefers NF Medication 
3 0 2 1 0 0 
Marginal Value for NF Decision: 
Reason Listed "Need*/Requir* OR 
Patient Need*/Require* 
1 0 0 0 1 0 
Pharmacological Reason: Drug 
Route Conflict 
1 0 0 0 0 1 
Specialist Recommendation 1 1 0 0 0 0 
Therapeutic Failure / Intolerant to 
formulary alternatives: 
[Unspecified or Medication Not 
Listed] 
1 1 0 0 0 0 
Total 36 23 (63.89%) 3 (8.33%) 1 (2.78%) 8 (22.22%) 1 (2.78%) 
  231 
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Table 4: Frequency of Discordant NFM Alert Override Reasons  
Initiate Non-Formulary 
Override Reason Classification 
Final NFM Override Reason Category (Post-Chart Review) 
Total 
Frequency 
of 
Discordant 
Reason for 
NFM Alert 
Override  
Blank 
Disease or 
Condition 
Listed 
Home or 
Pre-
Admission 
Medication 
Marginal Value for 
NF Decision: 
MD/Attending/Team 
Request, Prefers, NF 
Medication 
Pharmacological 
Reason: Drug 
Route Conflict 
Pharmacological 
Reason: Others 
Specialist 
Recommendation 
Therapeutic 
Failure / 
Intolerant 
to 
formulary 
alternatives: 
[Medication 
Listed] 
Blank 51 94.1% 3 42 3 0 0 0 0 3 
Disease or Condition Listed 64 7.8% 0 59 4 0 1 0 0 0 
Home or Pre-Admission 
Medication 
38 10.5% 0 1 34 0 0 0 3 0 
Marginal Value for NF 
Decision: 
30 93.3% 0 16 10 2 1 0 0 1 
MisCommunication: 
Medication use direction 
3 100.0% 0 2 1 0 0 0 0 0 
Acknowledge NF status 2 100.0% 0 1 1 0 0 0 0 0 
Content Free 1 100.0% 0 1 0 0 0 0 0 0 
MD/Attending/Team 
Request, Prefers NF Medication 
11 81.8% 0 7 2 2 0 0 0 0 
Others 2 100.0% 0 2 0 0 0 0 0 0 
Patient 
Preference/Request 
2 100.0% 0 0 1 0 1 0 0 0 
Reason Listed 
"Appropriate, Effective, 
Indicated, Medical Necessity, 
No Alternative 
1 100.0% 0 0 0 0 0 0 0 1 
Reason Listed 
"Need*/Requir* OR Patient 
Need*/Require* 
8 100.0% 0 3 5 0 0 0 0 0 
Pharmacological Reason:  4 50.0% 0 1 0 0 1 1 0 1 
Contraindication 1 100.0% 0 1 0 0 0 0 0 0 
Drug Route Conflict 1 0.0% 0 0 0 0 1 0 0 0 
Others 2 50.0% 0 0 0 0 0 1 0 1 
Specialist Recommendation: 
Specialist / Other Service 
Recommended 
10 20.0% 0 2 0 0 0 0 8 0 
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Therapeutic Failure / 
Intolerant to formulary 
alternatives:  
9 33.3% 0 1 0 0 0 0 0 8 
Medication Listed 6 0.0% 0 0 0 0 0 0 0 6 
Unspecified or Medication 
Not Listed 
3 33.3% 0 1 0 0 0 0 0 2 
Total 206   3 122 51 2 3 1 11 13 
  232 
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Discussion 233 
Our observational study found approximately one-fifth of NFM alerts at our institution are 234 
inappropriately overridden. Non-oral NFMs alerts were more likely to be inappropriately 235 
overridden compared to oral NFMs. We also found NFM alerts overridden with ‘blank’ were 236 
more likely to be inappropriately overridden. Contrary, alerts overridden with ‘disease or 237 
condition’ reasons are less likely to be inappropriately overridden. In-depth chart review found 238 
the failure to trial a formulary alternative is the most common reason for a NFM alert override 239 
to be inappropriate. Lastly, NFM alerts overridden with ‘blank’ or ‘marginal value’ reasons often 240 
had justifiable formulary deviation reasons in the medical notes, but poorly documented in the 241 
NFM alert pop-up interface.  242 
To our knowledge there are no studies evaluating the appropriateness of NFM alert 243 
overrides. This is likely attributed to the resource-intensive task of creating appropriateness 244 
criteria for each NFM. Thus, we are unsure of how our findings compared to other institutions. 245 
However, evaluating NFM alerts is inherently evaluating NFM use. Therefore, inappropriate 246 
NFM usage frequencies may provide some estimation of the frequency of inappropriate NFM 247 
alerts overrides.  248 
Available studies suggest the frequency of inappropriate NFM usage is approximately 60% 249 
to 70%. Specifically, a small 6-week prospective study at an academic medical center found 61% 250 
of NFM use failed to comply to institution criteria8 and a study evaluating the impact of a 251 
comprehensive formulary management system from a no structured system decreased NFM 252 
utilization from 17.8 to 5.9 medications per 100 admissions. This suggests an upper 67% bound 253 
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of inappropriate NFM use.2 Our lower frequency is likely attributed to BWH’s ‘relaxed’ 254 
formulary and our sample was composed of NFMs previously approved by pharmacist for use, 255 
hence also decreasing the number of inappropriate alert overrides.  256 
The literature on formulary CDS is scarce. Our secondary findings provide important 257 
perspective on the better design of these informatic tools for automated formulary 258 
management.  First, improvement in NFM alert systems should be prioritized to focus on non-259 
oral NFMs. Non-oral NFMs have greater formulary cost-implications than oral NFMs. Sweet et 260 
al estimated the successful conversion of non-oral NFMs to a formulary alternative saves $7.04 261 
to $94.60 compared to $16.62 in oral NFMs.4 Our study found non-oral NFM alert overrides 262 
more likely to be inappropriate compared to oral NFMs. Thus, optimization of automated 263 
formulary management with non-oral NFMs is more likely to ensure formulary cost-savings. 264 
Second, it is not surprising that the provision of no reason (‘blank’) to NFM alerts overrides 265 
were disproportionately inappropriate. This is likely reflective of BWH’s ‘relaxed’ formulary, but 266 
also a characteristics volunteer free-texted alert system.16 Mandating the provision of an 267 
override reason may decrease the frequency of inappropriate NFM alert overrides. 268 
Third, we expected NFM alerts overridden with clinical reasons (pharmacological, specialist 269 
recommendation, and therapeutic failure / intolerant to formulary alternatives) to be more 270 
likely appropriate, but was only able to demonstrate this relationship with alerts overridden 271 
with ‘disease or condition’ reasons. The inability to demonstrate this hypothesis with the 272 
former clinical reasons is likely due to their small numbers in our sample. Our previous study 273 
found clinical reasons were rarely entered into our alert system (cite AJHP study), which is 274 
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surprising with our sampling being composed of only approved NFM overrides. Chart review 275 
found nearly all ‘blank’ (45 of the 51) and ‘marginal value’ (28 of the 30) reasons were of clinical 276 
reasons and potentially appropriate in our post-hoc analysis (Table 4). Thus, mandating the 277 
provision of any override reason is likely to increase the frequency of alerts overridden with 278 
clinical reasons, inherently decreasing the frequency of inappropriate NFM alert overrides.  279 
Fourth, chart review found inappropriate NFM alert overrides were largely attributed to 280 
prescriber not trialing formulary alternatives prior to the NFM. This is likely due to BWH’s large 281 
number of NFMs managed by a soft stop, where guidance to formulary alternatives is not 282 
provided. Listing formulary alternatives in the pop-up alerts is likely to facilitate the use and 283 
trial of formulary alternatives, hence decreasing the frequency of inappropriate NFM alert 284 
overrides. A recent study found an obtrusive, hard-stop, pop-up alert prompting formulary 285 
interchange decreased non-formulary non-adherence by 65%.17 In addition a list of formulary 286 
alternatives that is clear, concise, and include links to additional information may further 287 
decrease the frequency of inappropriate NFM alert overrides.11,18-20   288 
Limitations 289 
Our study has a number of limitations. First, our study was retrospective and we limited 290 
our review to the information documented in the inpatient medical notes. There were three 291 
‘blank’ overrides where no citation or information regarding the rationale of NFM use was 292 
found in the inpatient notes. Contrary, there were numerous incidences where ‘blank’ 293 
overrides were actually justified after chart review. This leads us to infer that potentially 294 
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prescribers could have discussed the rationale for NFM use with the team, specialist, or 295 
rounding pharmacist, but failed to document appropriately in the NFM alert pop-up window.  296 
Second, our study was undertaken at a single medical center with an in-house 297 
developed COPE system and utilized appropriateness criteria specific to one institution. Thus 298 
the results may not be fully generalizable to other institutions and medication ordering system. 299 
Nevertheless, our findings provide important perspective on the design of computerized 300 
formulary management systems and formulary-based CDS, which may further ensure formulary 301 
cost-savings, quality of care, and medication safety. In addition, our study empirically applied a 302 
previously developed general appropriateness criteria; thus the presented study may serve as a 303 
model for future formulary-based CDS studies and generate more override appropriateness 304 
evaluation.  305 
Lastly, our analysis focused on only a subset of NFM alert overrides, the most approved 306 
and highest costing NFMs. Thus, it remains unknown how our findings might have differ with 307 
the inclusion of all NFMs. Yet such study is likely infeasible due to the need to create 308 
appropriateness criteria for all NFMs. Our reasonable decision to focus on the highest cost and 309 
most approved NFMs was to identify insight that may yield the greatest improvement in the 310 
use of alerts for formulary management. 311 
Conclusion 312 
To our knowledge, our study is the first to empirically evaluate the appropriateness of 313 
NFM alerts overrides in the inpatient setting. Evaluating the effectiveness of these overrides is 314 
inherently evaluating NFM usage. This is a labor-intensive task and requires the creation of 315 
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appropriateness criteria for each NFM. We circumvented this issue by tailoring an empirically 316 
developed NFM alert override general appropriateness algorithm to our institution’s NFM 317 
policy and use criteria and focused on the most approved and high costing NFMs. The present 318 
study conservatively estimates that one in five NFM alert overrides is inappropriately 319 
overridden and at minimum mandating an override reason for each NFM alert override and 320 
adding a list of formulary alternatives to each NFM alert may decrease the frequency of 321 
inappropriate NFM alert overrides. 322 
This study was funded by grant #U19HS021094 from the Agency for Healthcare Research and 323 
Quality (AHRQ).  324 
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